Vascular protective effects of statin-related increase in serum 25-hydroxyvitamin D among high-risk cardiac patients

Journal of Cardiovascular Medicine

Volumn 16, Issue 1, 2015, Pages 51-58

  Chan, Yap Hang ^a   Lau, Kui Kai ^a   Yiu, Kai Hang ^a   Li, Sheung Wai ^b   Tam, Sidney ^c   Lam, Tai Hing ^a   Lau, Chu Pak ^a   Siu, Chung Wah ^a   Cheung, Bernard M Y ^c   Tse, Hung Fat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUNG WAH HOSPITAL   (Hong Kong)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

25 hydroxyvitamin d; Carotid intima media thickness; Circulating endothelial progenitor cells; Pleiotropic effects; Statin therapy

Indexed keywords

25 HYDROXYVITAMIN D; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; BRAIN ISCHEMIA; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLYCEMIC CONTROL; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; VITAMIN BLOOD LEVEL; BLOOD; BRAIN INFARCTION; CORONARY DISEASE; ECHOGRAPHY; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN INFARCTION; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, LDL; CORONARY DISEASE; ENDOTHELIAL PROGENITOR CELLS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; VITAMIN D;

EID: 84918563524     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000026     Document Type: Article

References (41)

1. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-1956.
2. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117:503-511.
3. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93:3927-3935.
4. McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease: A narrative review. Ann Intern Med 2011; 155:820-826.
5. Dong Y, Stallmann-Jorgensen IS, Pollock NK, et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010; 95:4584-4591.
6. Harris RA, Pedersen-White J, Guo DH, et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African- American adults. Am J Hypertens 2011; 24:557-562.
7. Witham MD, Dove FJ, Khan F, et al. Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction-A randomised controlled trial. Int J Cardiol 2013; 167:745-749.
8. Yavuz B, Ertugrul DT, Cil H, et al. Increased levels of 25 hydroxyvitamin D and 1, 25-dihydroxyvitamin D after rosuvastatin treatment: A novel pleiotropic effect of statins? Cardiovasc Drugs Ther 2009; 23:295-299.
9. Perez-Castrillon JL, Vega G, Abad L, et al. Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 2007; 99:903-905.
10. Sathyapalan T, Shepherd J, Arnett C, et al. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. Clin Chem 2010; 56:1696-1700.
11. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004; 43:1731- 1737.
12. Rajagopalan S, Brook RD. The indoor-outdoor air-pollution continuum and the burden of cardiovascular disease: An opportunity for improving global health. Global Heart 2012; 7:207-213.
13. Vassiliadis E, Barascuk N, Didangelos A, Karsdal MA. Novel cardiac specific biomarkers and the cardiovascular continuum. Bio mark Insights 2012; 7:45-57.
14. Burgmaier M, Heinrich C, Marx N. Cardiovascular effects of GLP-1 and GLP-1-based therapies: Implications for the cardiovascular continuum in diabetes? Diabet Med 2013; 30:289-299.
15. Tereshchenko LG, Cygankiewicz I, McNitt S, et al. Predictive value of beat-to-beat QT variability index across the continuum of left ventricular dysfunction: competing risks of noncardiac or cardiovascular death and sudden or nonsudden cardiac death. Circ Arrhythm Electrophysiol 2012; 5:719-727.
16. Chan YH, Lau KK, Yiu KH, et al. Isoflavone intake in persons at high risk of cardiovascular events: Implications for vascular endothelial function and the carotid atherosclerotic burden. Am J Clin Nutr 2007; 86:938-945.
17. Chan YH, Lau KK, Yiu KH, et al. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur Heart J 2008; 29:2800-2807.
18. Chan YH, Siu CW, Yiu KH, et al. Abnormal vascular function in PR-interval prolongation. Clin Cardiol 2011; 34:628-632.
19. Chan YH, Lam TH, Lau KK, et al. Dietary intake of phytoestrogen is associated with increased circulating endothelial progenitor cells in patients with cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2011; 18:360-368.
20. Yiu YF, Chan YH, Yiu KH, et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96:E830-E835.
21. Tsivgoulis G, Vemmos K, Papamichael C, et al. Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke 2006; 37:1913-1916.
22. Wattanakit K, Folsom AR, Chambless LE, Nieto FJ. Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2005; 149:606-612.
23. Yiu YF, Yiu KH, Siu CW, et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013; 227:140-146.
24. Grimes DS. Are statins analogues of vitamin D? Lancet 2006; 368:83- 86.
25. Cooper-DeHoff RM, Pacanowski MA, Pepine CJ. Cardiovascular therapies and associated glucose homeostasis: Implications across the dysglycemia continuum. J Am Coll Cardiol 2009; 53 (5 Suppl):S28-S34.
26. Guryev O, Carvalho RA, Usanov S, et al. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc Natl Acad Sci U S A 2003; 100:14754-14759.
27. Dotsenko O, Chackathayil J, Patel JV, et al. Candidate circulating biomarkers for the cardiovascular disease continuum. Curr Pharm Des 2008; 14:2445-2461.
28. Kajinami K, Takekoshi N, Matsui S, et al. Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 2003; 92:1113-1116.
29. Chrysant SG, Chrysant GS, Chrysant C, Shiraz M. The treatment of cardiovascular disease continuum: Focus on prevention and RAS blockade. Curr Clin Pharmacol 2010; 5:89-95.
30. Kojima G, Bell C, Abbott RD, et al. Low dietary vitamin D predicts 34-year incident stroke: The Honolulu Heart Program. Stroke 2012; 43:2163- 2167.
31. Oh J, Weng S, Felton SK, et al. 1, 25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120:687-698.
32. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008; 52:828-832.
33. Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials. Lipids Health Dis 2012; 11:42.
34. Buyukinan M, Ozen S, Kokkun S, Saz EU. The relation of vitamin D deficiency with puberty and insulin resistance in obese children and adolescents. J Pediatr Endocrinol Metab 2012; 25:83-87.
35. Argacha JF, Egrise D, Pochet S, et al. Vitamin D deficiency-induced hypertension is associated with vascular oxidative stress and altered heart gene expression. J Cardiovasc Pharmacol 2011; 58:65-71.
36. Richards JB, Valdes AM, Gardner JP, et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr 2007; 86:1420-1425.
37. de Boer IH, Ioannou GN, Kestenbaum B, et al. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2007; 50:69-77.
38. Kosch M, Hausberg M, Vormbrock K, et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 2000; 47:813-818.
39. Deo R, Katz R, Shlipak MG, et al. Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study. Hypertension 2011; 58:1021-1028.
40. Husemoen LL, Thuesen BH, Fenger M, et al. Serum 25(OH)D and type 2 diabetes association in a general population: A prospective study. Diabetes Care 2012; 35:1695-1700.
41. Gonzalez-Juanatey JR, Cordero A. Benefits of delapril in hypertensive patients along the cardiovascular continuum. Expert Rev Cardiovasc Ther 2013; 11:271-281.